Related Experiment Videos
[Relation between serum eosinophil cationic protein (ECP) level and asthma attack in children]
N Ishigaki1, C Masuhara, K Sakamaki
1Department of Pediatrics, Kyorin University School of Medicine.
Arerugi = [Allergy]
|February 24, 2001
Summary
Serum eosinophil cationic protein (sECP) levels can predict childhood asthma attacks. Lower sECP levels indicate fewer attacks, suggesting its use in monitoring allergy activity and treatment plans.
Area of Science:
- Allergy and Immunology
- Pediatric Pulmonology
- Biomarker Research
Context:
- Childhood asthma management requires accurate prediction of exacerbations.
- Current methods for predicting asthma attacks have limitations.
- Serum eosinophil cationic protein (sECP) is a potential biomarker for allergic inflammation.
Purpose:
- To investigate the correlation between serum eosinophil cationic protein (sECP) levels and childhood asthma attack frequency.
- To evaluate the predictive value of sECP for asthma exacerbations.
- To determine the utility of sECP in monitoring disease activity and guiding treatment.
Summary:
- This study followed 339 children with asthma for 57 weeks, measuring sECP, blood eosinophils, and serum total IgE (tIgE).
- sECP levels significantly correlated with asthma attack frequency, blood eosinophil count, and tIgE.
- Lower sECP levels were associated with fewer asthma attacks, particularly in patients without other allergic diseases, suggesting predictive value for events within two weeks.
Impact:
- Serum eosinophil cationic protein (sECP) serves as a valuable objective marker for assessing allergic inflammation activity in childhood asthma.
- Periodic sECP measurement can aid clinicians in objectively monitoring symptom improvement and tailoring treatment strategies, including the use of medications like DSCG or BDP.
- The findings support the integration of sECP monitoring into routine clinical practice for enhanced childhood asthma management and prediction of exacerbations.